Recombinant human TNK tissue-type plasminogen activator (rhTNK-tPA) versus alteplase (rt-PA) as fibrinolytic therapy for acute ST-segment elevation myocardial infarction (China TNK STEMI): protocol for a randomised, controlled, non-inferiority tr | |
Wang Hai-Bo; Ji Ping; Zhao Xing-Shan; Xu Haiyan; Yan Xiao-Yan; Yang Qin; Yao Chen; Gao Run-Lin; Wu Yang-Feng; Qiao Shu-Bin | |
2017 | |
卷号 | 7期号:9页码:e016838 |
关键词 | China Fibrinolysis alteplase myocardial infarction recombinant human TNK tissue-type plasminogen activator |
ISSN号 | 2044-6055 |
DOI | 10.1136/bmjopen-2017-016838 |
URL标识 | 查看原文 |
收录类别 | SCIE ; PUBMED |
内容类型 | 期刊论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/6364719 |
专题 | 中国医学科学院 北京协和医学院 |
推荐引用方式 GB/T 7714 | Wang Hai-Bo,Ji Ping,Zhao Xing-Shan,et al. Recombinant human TNK tissue-type plasminogen activator (rhTNK-tPA) versus alteplase (rt-PA) as fibrinolytic therapy for acute ST-segment elevation myocardial infarction (China TNK STEMI): protocol for a randomised, controlled, non-inferiority tr[J],2017,7(9):e016838. |
APA | Wang Hai-Bo.,Ji Ping.,Zhao Xing-Shan.,Xu Haiyan.,Yan Xiao-Yan.,...&Qiao Shu-Bin.(2017).Recombinant human TNK tissue-type plasminogen activator (rhTNK-tPA) versus alteplase (rt-PA) as fibrinolytic therapy for acute ST-segment elevation myocardial infarction (China TNK STEMI): protocol for a randomised, controlled, non-inferiority tr.,7(9),e016838. |
MLA | Wang Hai-Bo,et al."Recombinant human TNK tissue-type plasminogen activator (rhTNK-tPA) versus alteplase (rt-PA) as fibrinolytic therapy for acute ST-segment elevation myocardial infarction (China TNK STEMI): protocol for a randomised, controlled, non-inferiority tr".7.9(2017):e016838. |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论